Market Summary The global market size for Acute Respiratory Distress Syndrome (ARDS) was USD 618.82 Million in 2019 and is projected to reach USD 990.88 Million by 2027, with a CAGR of 6% during the forecast period.

Overview of ARDS ARDS is a swiftly progressing lung disease observed in critically ill patients, characterized by fluid leakage into the lungs, leading to breathing difficulties or impossibility. Despite advancements in understanding its pathophysiology and management, ARDS remains associated with high mortality rates.

Get a sample copy of the Acute Respiratory Distress Syndrome (ARDS) Market report: https://www.reportsanddata.com/download-free-sample/5848

Types of ARDS ARDS can be classified into direct and indirect lung injuries. Direct injuries comprise aspiration, pneumonia, and trauma, while indirect injuries involve severe infection or sepsis, pancreatitis, blood transfusions, burns, and adverse reactions to medications. Symptoms encompass cough, shortness of breath, fever, elevated heart rates, and rapid breathing. Risk factors include obesity, alcohol abuse, chemotherapy, and low levels of blood proteins.

Global Impact According to a World Health Organization (WHO) survey, ARDS affects over 3 million individuals worldwide. Air pollution, primarily stemming from vehicle emissions, plays a significant role in contributing to ARDS. The market is anticipated to expand due to the escalating levels of air pollution and health issues related to lifestyle.

Device Types The ARDS market is segmented into monitoring devices, diagnostic devices, and therapeutic devices. Mechanical ventilators and nebulizers dominate the market, with nebulizers gaining traction due to their cost-effectiveness and widespread availability.

Treatment Treatment involves general supportive measures, ventilator strategies, and addressing the underlying condition. Pharmacological interventions, though researched for over a decade, have seen limited success.

End Users Hospitals are expected to lead the market share due to favorable reimbursement policies in developed countries, while clinics are projected to experience growth with rising cases of sudden respiratory attacks.

Regional Growth The Asia-Pacific region shows the highest growth in market revenue share, driven by advancements in healthcare in countries like China, India, and Japan. These countries also witness an increase in lung injury and brain damage from car accidents.

Market Statistics

• The global ARDS market was valued at USD 618.82 Million in 2019, expected to reach USD 990.88 Million by 2027, with a CAGR of 6%.
• Mechanical ventilators and nebulizers hold the highest market share for devices.
• Invasive ventilators in the ARDS market are expected to reach XX million in 2027 with a significant CAGR between 2020 and 2027.
• The fibroproliferate market for ARDS is anticipated to grow at a remarkable CAGR from 2020 to 2027.

Market Drivers

• Rising air pollution and technological advancements are expected to support market growth.
• Competitive Landscape: Key players plan acquisitions, while smaller players focus on R&D for innovative products.

Major Companies Faron Pharmaceuticals, BioMarck Pharmaceuticals, GE Healthcare, Hamilton Medical AG, Smiths Medical, Athersys, GlaxoSmithKline, Altor Bioscience, BPL Technologies, and Mondobiotech.

Market Segmentation The report forecasts revenue growth globally, regionally, and by country, analyzing trends in sub-segments from 2017 to 2027. Segments include device type, injury type, severity type, treatment type, sales channel type, end-user type, and region.

Explore Trending Reports:

Tetrahydrofuran (THF) Market -https://bhagyashrishewale.blogspot.com/2023/06/tetrahydrofuran-thf-market-is-expected.html

Benzoic Acid Market -https://bhagyashrishewale.blogspot.com/2023/06/benzoic-acid-market-is-expected-to.html

Acrylic Monomers Market -https://bhagyashrishewale.blogspot.com/2023/06/acrylic-monomers-market-to-exceed.html

Bitumen Membranes Market -https://bhagyashrishewale.blogspot.com/2023/06/bitumen-membranes-market-to-exceed.html

Request a customization of the report: https://www.reportsanddata.com/request-customization-form/5848

Thank you for reading our report. To know more about the customization or any query about the report contents, please connect with us and our team will ensure the report is tailored to meet your requirements.

About Reports and Data    

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

(Head of Business Development)

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Blogs | Press Release | Industry News | Our competencies

Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports

Browse More Latest Reports @ https://www.reportsanddata.com/report

Browse Latest Blogs: https://www.reportsanddata.com/blogs

Browse Latest Press Release: https://www.reportsanddata.com/press-release